NYSE$EHC

Encompass Health Corp · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Encompass Health's third quarter performance was strong, with revenue and Adjusted EBITDA increasing.

Encompass Health Corporation reported strong results for the third quarter ended September 30, 2024. Revenue increased by 11.9% and Adjusted EBITDA increased by 13.4%. The company also increased its full-year guidance.

  • Revenue growth of 11.9% resulted primarily from discharge growth of 8.8%, including same-store growth of 6.8%. Net revenue per discharge grew 2.5%.
  • Cash flows provided by operating activities increased 24.4% to $267.8 million, primarily due to an increase in net income partly offset by higher cash tax payments.
  • Adjusted EBITDA increased 13.4%, primarily from increased revenue.
  • The Company increased its full-year guidance.

Headline financials

Total Revenue

$1.35B

Previous: $1.21B+11.9%
EPS

$1.06

Previous: $0.86+23.3%
Discharges

62.7K

Previous: 57.7K+8.8%
Net patient revenue per discharge

$21K

Previous: $20.5K+2.5%
Adjusted EBITDA

$269M

No prior period
Capital Expenditures

-$148M

Previous: -$361M+59.1%
Free Cash Flow

$108M

Previous: -$275M+139.3%
Net Income

$108M

Previous: $85.3M+26.8%
Operating Income

-$256M

Previous: -$234M-9.4%
Cash & Equivalents

$148M

Previous: $99.7M+48.2%
Total Assets

$6.46B

Previous: $5.96B+8.3%
Stock-Based Comp

$12.9M

Previous: $13.7M-5.8%

Revenue & EPS history

Encompass Health · Revenue · Quarterly

$1.35B

Q3 2024+11.9%vs Q3 2023
Beat estimate in 6 of 15 quarters(40%)
ActualEstimate

Forward guidance

The Company increased its full-year guidance as follows:

Tailwinds

  • Net operating revenue: $5,325 to $5,375 million
  • Adjusted EBITDA: $1,070 to $1,090 million
  • Adjusted earnings per share from continuing operations attributable to Encompass Health: $4.19 to $4.33

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+1.2%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+2.5%

Avg return

30 days after

64%

42 / 66 earnings

Positive

+11.8%

Q1 2025

Best reaction

-9.0%

Q1 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.1%+5.0%+6.0%
Q4 2025+5.9%+13.9%+7.4%
Q3 2025-6.9%-6.8%-7.5%
Q1 2025+11.8%+15.4%+17.2%
Q4 2024+1.3%-0.6%+0.7%
Q3 2024+7.0%+5.8%+10.0%
Q2 2024-8.7%-7.5%+1.0%
Q1 2024+0.3%+1.4%+2.5%
Q4 2023+1.7%+1.9%+5.9%
Q3 2023-1.9%+0.9%+6.7%
Q2 2023+5.0%+6.4%+7.6%
Q1 2023+0.7%-0.6%-5.9%
Q4 2022+1.6%+3.1%-9.1%
Q3 2022+6.4%+11.1%+16.6%
Q2 2022+0.6%+4.5%-4.0%
Q1 2022+2.6%+2.5%-2.0%
Q4 2021+1.5%-2.9%+8.8%
Q3 2021-6.0%-5.8%-9.8%
Q2 2021+0.7%+3.5%-4.1%
Q1 2021-1.6%-2.7%-2.5%
Q4 2020-3.9%-6.2%-6.1%
Q3 2020-2.6%-3.0%+25.9%
Q2 2020+4.5%+3.1%-6.4%
Q1 2020-1.1%-7.1%+6.4%
Q4 2019+0.4%+3.1%-2.6%
Q3 2019-5.8%+2.0%+5.5%
Q2 2019-4.0%-7.4%-12.6%
Q1 2019+5.3%+3.6%-4.6%
Q4 2018-4.4%-3.5%-13.3%
Q3 2018-5.7%-4.0%+1.4%
Q2 2018+8.8%+5.9%+17.4%
Q1 2018+7.2%+7.3%+10.3%
Q4 2017+3.0%+3.9%+7.7%
Q3 2017+1.8%+2.0%+8.7%
Q2 2017+1.9%-0.2%+3.6%
Q1 2017+7.9%+10.0%+6.3%
Q4 2016+0.1%+0.5%-1.9%
Q3 2016+1.8%+0.7%+5.6%
Q2 2016+6.7%+3.1%-0.3%
Q1 2016+10.9%
Q4 2015+9.2%
Q3 2015-0.3%
Q2 2015-2.9%
Q1 2015-9.0%
Q4 2014-4.7%
Q3 2014-3.0%
Q2 2014+7.4%
Q1 2014-0.4%
Q4 2013-2.8%
Q3 2013+0.6%
Q2 2013+4.7%
Q1 2013+3.1%
Q4 2012+7.2%
Q3 2012+2.5%
Q2 2012-3.7%
Q1 2012+9.2%
Q4 2010+3.9%
Q4 2011+3.9%
Q3 2011-1.0%
Q2 2011-9.0%
Q1 2010+0.4%
Q1 2011+2.5%
Q4 2008+7.8%
Q3 2010+2.2%
Q2 2010-1.0%
Q4 2009-1.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro